Related Experiment Videos

Schistosoma haematobium infection in children in Britain

M Samuel1, D Misra, V Larcher

  • 1Department of Paediatric Surgery, Royal London Hospital, London, UK.

BJU International
|February 15, 2000
PubMed

Insights

Schistosoma haematobium infection, causing haematuria in children, is a concern for travellers to Africa and the Middle East. Early diagnosis and treatment with praziquantel are crucial for reversible outcomes.

Area of Science:

  • Medical Parasitology
  • Pediatric Nephrology
  • Tropical Medicine

Background:

  • Schistosoma haematobium is a parasitic worm causing urogenital schistosomiasis.
  • The infection is endemic in parts of Africa and the Middle East.
  • Cases in non-endemic regions like Britain may be linked to travel or ethnic minority groups.

Purpose of the Study:

  • To raise awareness among healthcare professionals about Schistosoma haematobium.
  • To emphasize its presence in specific ethnic minority groups in Britain and travellers.
  • To include it in the differential diagnosis for pediatric haematuria.

Main Methods:

  • A 2-year observational study of six pediatric patients.
  • Patients presented with haematuria and a history of travel to endemic areas.
  • Diagnosis confirmed by identifying Schistosoma haematobium ova in urine samples.

Main Results:

  • All six patients were diagnosed with S. haematobium infection.
  • Symptoms of dysuria and haematuria appeared 2-3 months post-infection.
  • Terminal urine samples after midday exercise were diagnostic for S. haematobium ova.
  • Praziquantel chemotherapy proved effective.

Conclusions:

  • Schistosoma haematobium infection is treatable if diagnosed early, preventing irreversible fibrotic lesions.
  • Midday exercise-induced terminal urine sampling is a reliable diagnostic method.
  • Consider S. haematobium in the differential diagnosis of haematuria for travellers and specific ethnic groups.
Abstract

Related Concept Videos